Stay informed with the latest updates for the inheritable blood disorders community. IndustryFDA Gives Priority Review to Gilead's HCV Drug SofosbuvirJul 1, 2013 IndustryFDA Accepts Application for Biogen's Longer-Lasting FVIII ProductJun 1, 2013 IndustryJanssen's HCV Therapy Receives FDA Priority ReviewJun 1, 2013 IndustryBayer Discontinues rFVIIa Therapy TrialJun 1, 2013 IndustryAntiviral Oral Combination Treats Certain HCV PatientsMay 1, 2013 IndustryAchillion Drug Begins Phase 2 Trial in HCV PatientsMay 1, 2013 IndustryGilead Announces HCV Drug Sofosbuvir Clinical Trial ResultsMay 1, 2013 IndustryCSL Donates to WFH GAP ProgramMay 1, 2013 MedicalSeaweed Derivative Promotes Clotting in Hemophilia PatientsMay 1, 2013 MedicalNGC Accepts WFH's Hemophilia Management GuidelinesMay 1, 2013 IndustryBaxter Submits FDA Application for Prophylactic FEIBA for Inhibitor…Apr 1, 2013 MedicalHepatitis Researcher to Receive Canadian AwardApr 1, 2013 MedicalPediatric Organization Urges Ruling Out Bleeding Disorders…Apr 1, 2013 MedicalToddler with HIV Potentially CuredApr 1, 2013 IndustryFDA Accepts Biogen's Application for Longer-Lasting FVIII ProductApr 1, 2013 Pagination First page Previous page … Page 34 Page 35 Page 36 Page 37 Current page 38 Page 39 Page 40 Page 41 Page 42 … Next page Last page